Clinical Potential of Adult Vascular Progenitor Cells
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Cell therapy to treat vascular and cardiovascular diseases has evolved over the past decade with improved understanding of progenitor cell mobilization, recruitment, and differentiation. The beneficial effects seen in several preclinical studies have prompted translation of adult vascular progenitor therapy to clinical trials. To date, progenitor cells isolated from bone marrow and peripheral blood have been tested in the context of acute myocardial infarction and chronic ischemic cardiomyopathy, with moderate benefit. This therapeutic effect occurs despite a relatively small number of injected progenitor cells and short-term residence in the target zone. Thus, indirect benefits, such as paracrine factors released from these cells, have been suggested as significant contributors to therapeutic efficacy. Several additional vascular progenitors of endothelial, smooth muscle, mesenchymal, and cardiac origin have been identified that may contribute to vasculogenesis. Indeed, a unifying paradigm for the most effective cell therapy strategies to date appears to be robust support of angiogenesis. Here we discuss a number of progenitor cells that currently show potential as cardiovascular therapeutics, either singly or in combination. We look at emerging cell types and disease targets that may be exploited for therapeutic benefit and future strategies that may maximize clinical efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Cited by
Exosomes From Human CD34 + Stem Cells Mediate Their Proangiogenic Paracrine Activity
Sahoo, S., Klychko, E., Thorne, T., Misener, S., Schultz, K. M., Millay, M., Ito, A., Liu, T., Kamide, C., Agrawal, H., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.253286 · Cited by 603
Angiogenic Mechanisms of Human CD34 + Stem Cell Exosomes in the Repair of Ischemic Hindlimb
Mathiyalagan, P., Liang, Y., Kim, D., Misener, S., Thorne, T., Kamide, C. E., Klyachko, E., Losordo, D. W., Hajjar, R. J., & Sahoo, S. (2017) · Circulation Research · doi:10.1161/circresaha.116.310557 · Cited by 291
Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology
Hodgkinson, C. P., Bareja, A., Gomez, J. A., & Dzau, V. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.305373 · Cited by 273
Brandau, S., Jakob, M., Hemeda, H., Bruderek, K., Janeschik, S., Bootz, F., & Lang, S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410207 · Cited by 155
Vasculogenesis: A new piece of the endometriosis puzzle
Laschke, M. W., Giebels, C., & Menger, M. D. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr023 · Cited by 136
“…during wound healing (Asahara et al., 1999; Liu et al., 2010), limb ischaemia (Hur et al., 2007), remodelling after acute myocardial infarction (Kumar and Caplice, 2010), atherosclerosis (Sata et al., 2002; Xu, 2006), fracture healing (Lee et al., 2008; Matsumoto et al., 2008) and tumour…”
Background
Metadata
- Authors
- Kumar, A. H. S., & Caplice, N. M.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2010-06
- Volume
- 30
- Issue
- 6
- Pages
- 1080-1087
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2099136912
- Cited by
- 100
- References
- 1
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.